These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26622536)

  • 1. Clinical benefits of metformin in gynecologic oncology.
    Imai A; Ichigo S; Matsunami K; Takagi H; Yasuda K
    Oncol Lett; 2015 Aug; 10(2):577-582. PubMed ID: 26622536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Cellular Mechanisms of Metformin in Cervical Cancer.
    Chen YH; Wang PH; Chen PN; Yang SF; Hsiao YH
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.
    Irie H; Banno K; Yanokura M; Iida M; Adachi M; Nakamura K; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
    Oncol Lett; 2016 Feb; 11(2):1287-1293. PubMed ID: 26893732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metformin--new treatment strategies for gynecologic neoplasms].
    Milewicz T; Kiałka M; Mrozińska S; Ociepka A; Krzysiek J
    Przegl Lek; 2013; 70(2):81-4. PubMed ID: 23879009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and gynecologic cancers.
    Stine JE; Bae-Jump V
    Obstet Gynecol Surv; 2014 Aug; 69(8):477-89. PubMed ID: 25144611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia.
    Top WMC; Kooy A; Stehouwer CDA
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old drug, new trick: repurposing metformin for gynecologic cancers?
    Febbraro T; Lengyel E; Romero IL
    Gynecol Oncol; 2014 Dec; 135(3):614-21. PubMed ID: 25455733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin as a Therapeutic Target in Endometrial Cancers.
    Lee TY; Martinez-Outschoorn UE; Schilder RJ; Kim CH; Richard SD; Rosenblum NG; Johnson JM
    Front Oncol; 2018; 8():341. PubMed ID: 30211120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What every dentist should know about metformin, diabetes, and cancer.
    Frykenberg MR; Schneider A; Bashirelahi N
    Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
    Dunn CJ; Peters DH
    Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin: a rising star to fight the epithelial mesenchymal transition in oncology.
    Barrière G; Tartary M; Rigaud M
    Anticancer Agents Med Chem; 2013 Feb; 13(2):333-40. PubMed ID: 22721394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
    Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
    Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
    Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
    Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin: risk-benefit profile with a focus on cancer.
    Provinciali N; Lazzeroni M; Cazzaniga M; Gorlero F; Dunn BK; DeCensi A
    Expert Opin Drug Saf; 2015 Oct; 14(10):1573-85. PubMed ID: 26359221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
    Tian J; Liang Y; Qu P
    Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data.
    Anisimov VN
    Curr Drug Targets; 2016; 17(4):439-46. PubMed ID: 25738299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.